Researchers are conducting studies to examine the effect of CBD when injected directly in the hippocampus area of the brain and whether CBD could be a viable treatment therapy for depression.
A group of researchers from the United States, Canada and Italy conducted a study on rats to determine if CBD could be a viable treatment option for neuropathic pain conditions.
The administration of the CBD treatments was able to reverse the negative effects induced by iron on the brain, including cell death, and demonstrated that cannabidiol has neuroprotective properties through its ability to prevent cell death.
The results of the study demonstrated to researchers that CBD was able to realign the brain to normal levels and possibly reduce psychotic symptoms.
“Cannabidiol may not only be a faster-acting antidepressant than conventional drugs but also improve the response to such drugs when taken in combination with them.”
CBD has previously demonstrated immunosuppressant properties which encouraged a new study examining the effectiveness of CBD as a treatment therapy option for MS patients.
Since the discovery that the endocannabinoid system is involved in emotional memory processing, researchers have begun to examine whether cannabidiol, or CBD, could be an effective therapeutic treatment option for those suffering from PTSD.
The study confirmed that CBD does in fact seem to possess anti-anxiety properties, which are triggered by CBD’s effect on the limbic and paralimbic brain areas.